19th week of 2022 patent applcation highlights part 10 |
Patent application number | Title | Published |
20220142933 | METHOD FOR PREPARING PROBIOTIC-LOADED MICROCAPSULE, PRODUCT OBTAINED FROM THE SAME, AND USE OF THE SAME | 2022-05-12 |
20220142934 | COMBINATION THERAPEUTICS AND METHODS FOR THE TREATMENT OF NEURODEGENERATIVE AND OTHER DISEASES | 2022-05-12 |
20220142935 | PHARMACEUTICAL COMPOSITION OF SIGLEC-BINDING AGENTS | 2022-05-12 |
20220142936 | THERAPEUTIC PROTEIN-BASED NANOPARTICLES FOR TREATING CANCER | 2022-05-12 |
20220142937 | PLANT-DERIVED EXOSOME-LIKE NANOPARTICLES INHIBIT BACTERIAL PATHOGENICITY | 2022-05-12 |
20220142938 | PLANT-DERIVED EXTRACELLULAR VESICLE (EVS) COMPOSITIONS AND USES THEREOF | 2022-05-12 |
20220142939 | TRANSFER SHEET | 2022-05-12 |
20220142940 | TRANSDERMAL PATCH | 2022-05-12 |
20220142941 | COMBINATION THERAPEUTIC REGIMENS WITH 1,6-DIBROMO-1,6-DIDEOXY-DULCITOL | 2022-05-12 |
20220142942 | CANNABINOID POUCHES | 2022-05-12 |
20220142943 | Method of Producing Cannabidiol Derived Products | 2022-05-12 |
20220142944 | TREATMENT OF SKIN DISORDERS WITH TOPICAL TAPINAROF-EGFR INHIBITOR COMPOSITIONS | 2022-05-12 |
20220142945 | FORMULATIONS INCLUDING DIHYDROHONOKIOL | 2022-05-12 |
20220142946 | CINNAMALDEHYDE DERIVATIVE COMPOUNDS AND METHODS OF USE FOR CINNAMALDEHYDE DERIVATIVE COMPOUNDS NICOTINE CESSATION | 2022-05-12 |
20220142947 | TRANSDERMAL DELIVERY FORMULATIONS | 2022-05-12 |
20220142948 | COMPOSITIONS AND METHODS FOR MODULATING METABOLIC REGULATORS OF T CELL PATHOGENICITY | 2022-05-12 |
20220142949 | DOSAGE REGIMEN FOR A S1P RECEPTOR AGONIST | 2022-05-12 |
20220142950 | BUPROPION AS A MODULATOR OF DRUG ACTIVITY | 2022-05-12 |
20220142951 | Patch | 2022-05-12 |
20220142952 | DALCETRAPIB IN THE TREATMENT OF SICKLE CELL TRAIT | 2022-05-12 |
20220142953 | LIDOCAINE PATCH AND METHODS OF USE THEREOF | 2022-05-12 |
20220142954 | METHOD OF INITIATING AND ESCALATING SOTALOL HYDROCHLORIDE DOSING | 2022-05-12 |
20220142955 | METHODS OF TREATING ORGANIC ACIDEMIAS | 2022-05-12 |
20220142956 | HICA FOR USE IN PROPHYLAXIS AND/OR TREATMENT OF A DISEASE OR CONDITION INVOLVING DEGRADATION OF CARTILAGE AND/OR DISRUPTION OF CARTILAGE HOMEOSTASIS AND/OR INTEGRITY | 2022-05-12 |
20220142957 | TERPENE BASED THERAPEUTIC DEEP EUTECTIC SYSTEM, METHOD OF OBTAINING AND USES THEREOF | 2022-05-12 |
20220142958 | MEDICINAL COMPOSITION HAVING EXCELLENT STABILITY | 2022-05-12 |
20220142959 | LEUCINE, ACETYL LEUCINE, AND RELATED ANALOGS FOR TREATING DISEASE | 2022-05-12 |
20220142960 | Compositions and Methods for Treating Metabolic Disorders | 2022-05-12 |
20220142961 | CCL5 Inhibitors | 2022-05-12 |
20220142962 | METHODS OF TREATING HYPERCHOLESTEROLEMIA | 2022-05-12 |
20220142963 | SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKERS AND USES THEREOF | 2022-05-12 |
20220142964 | PHARMACEUTICAL DOSAGE FORM OF COLESTIPOL | 2022-05-12 |
20220142965 | COMPOSITIONS COMPRISING CAROTENOIDS AND USE THEREOF | 2022-05-12 |
20220142966 | USE OF SUBSTITUTED HEXITOLS INCLUDING DIANHYDROGALACTITOL AND ANALOGS TO TREAT NEOPLASTIC DISEASE AND CANCER STEM CELLS INCLUDING GLIOBLASTOMA MULTIFORME AND MEDULLOBLASTOMA | 2022-05-12 |
20220142967 | Methods and Compositions for the Treatment of Multiple Sclerosis | 2022-05-12 |
20220142968 | ANAVEX2-73 FOR THE TREATMENT OF GENETIC NEURODEVELOPMENTAL DISORDERS | 2022-05-12 |
20220142969 | WATER-SOLUBLE CANNABINOID FORMULATIONS AND METHODS OF THEIR MAKING | 2022-05-12 |
20220142970 | CANNABIS INHALATION PRODUCTS AND METHODS OF PRODUCTION THEREOF | 2022-05-12 |
20220142971 | C-MET REGULATORY COMPOSITION AND ITS METHOD FOR TREATING LIVER DISEASE | 2022-05-12 |
20220142972 | PARASITICIDAL FORMULATIONS AND USE THEREOF | 2022-05-12 |
20220142973 | SMALL MOLECULE ANTIVIRAL DRUG TREATMENT FOR HUMAN PAPILLOMAVIRUS INFECTIONS | 2022-05-12 |
20220142974 | INHIBITION OF DIPEPTIDE REPEAT PROTEINS | 2022-05-12 |
20220142975 | Pharmaceutical Combination and Use Thereof | 2022-05-12 |
20220142976 | Nitrile-Containing Antiviral Compounds | 2022-05-12 |
20220142977 | METHODS OF TREATING CONDITIONS RELATED TO THE S1P1 RECEPTOR | 2022-05-12 |
20220142978 | Use of short chain fatty acids for the treatment and prevention of diseases and disorders | 2022-05-12 |
20220142979 | PHARMACEUTICAL COMPOSITION OF MDM2 INHIBITOR AND USE THEREOF FOR PREVENTING AND/OR TREATING DISEASE | 2022-05-12 |
20220142980 | PEGYLATED BILIRUBIN FOR THE TREATMENT OF HYPERLIPIDEMIA, OBESITY, FATTY LIVER DISEASE, CARDIOVASCULAR DISEASES AND TYPE II DIABETES | 2022-05-12 |
20220142981 | APREMILAST LIPOPHILIC TOPICAL PHARMACEUTICAL COMPOSITIONS | 2022-05-12 |
20220142982 | PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION OF EDARAVONE AND METHOD OF ADMINISTERING SAME | 2022-05-12 |
20220142983 | METHODS OF TREATING CANCER WITH FARNESYLTRANSFERASE INHIBITORS | 2022-05-12 |
20220142984 | Soft Chewable Pharmaceutical Products | 2022-05-12 |
20220142985 | AGENTS FOR TREATMENT OF ALCOHOL USE DISORDER | 2022-05-12 |
20220142986 | HIGH DOSAGE TEBIPENEM PIVOXIL TABLET FORMULATION | 2022-05-12 |
20220142987 | ANTI-FUNGAL AGENT | 2022-05-12 |
20220142988 | Materials and Methods for Enhanced Treatment and Prevention of Biofilms | 2022-05-12 |
20220142989 | DETECTING AND TREATING GROWTH HORMONE DEFICIENCY | 2022-05-12 |
20220142990 | EXTERNAL PREPARATION FOR TREATING A VASCULAR ANOMALY | 2022-05-12 |
20220142991 | METHODS AND COMPOSITIONS FOR TREATMENT OF L YSOSOMAL STORAGE DISORDER | 2022-05-12 |
20220142992 | FORMULATIONS, METHODS, KITS, AND DOSAGE FORMS | 2022-05-12 |
20220142993 | AFABICIN FORMULATION, METHOD FOR MAKING THE SAME AND USES THEREOF | 2022-05-12 |
20220142994 | Beta-Carboline Compounds And Use Thereof For The Non-Cytotoxic And Immunological Treatment Of Cancer | 2022-05-12 |
20220142995 | DUAL ATM AND DNA-PK INHIBITORS FOR USE IN ANTI-TUMOR THERAPY | 2022-05-12 |
20220142996 | PHARMACEUTICAL COMBINATION OF AN EP4 ANTAGONIST AND IMMUNE CHECKPOINT INHIBITORS FOR THE TREATMENT OF TUMOURS | 2022-05-12 |
20220142997 | METHODS OF TREATING GASTROINTESTINAL STROMAL TUMORS | 2022-05-12 |
20220142998 | Methods Of Treating Fabry Disease In Patients Having The G9331A Mutation In The GLA Gene | 2022-05-12 |
20220142999 | SUSTAINED RELEASE AMINOPYRIDINE COMPOSITION | 2022-05-12 |
20220143000 | TREATMENT OF AUTOIMMUNE DISEASES WITH COMBINATIONS OF RXR AGONISTS AND THYROID HORMONES | 2022-05-12 |
20220143001 | NOVEL PAN-RAF KINASE INHIBITOR AND USE THEREOF | 2022-05-12 |
20220143002 | SULFUR-CONTAINING COMPOUND BASED ON GLUTARIMIDE SKELETON AND APPLICATION THEREOF | 2022-05-12 |
20220143003 | COMPOSITIONS AND METHODS TO TREAT NON-ALCOHOLIC FATTY LIVER DISEASES (NAFLD) | 2022-05-12 |
20220143004 | USE OF HEXOKINASE 2/MITOCHONDRIA-DETACHING COMPOUNDS FOR TREATING HEXOKINASE-2 (HK2)-EXPRESSING CANCERS | 2022-05-12 |
20220143005 | NAPHTHALIMIDE DERIVATIVES AS ANTI-PARASITIC AGENTS FOR THE TREATMENT OF LEISHMANIASIS AS WELL AS VIRAL, BACTERIAL AND NEOPLASTIC DISEASES | 2022-05-12 |
20220143006 | METHODS OF TREATING CANCER WITH FARNESYLTRANSFERASE INHIBITORS | 2022-05-12 |
20220143007 | FORMULATIONS OF A SOMATOSTATIN MODULATOR | 2022-05-12 |
20220143008 | METHODS OF TREATING GASTROINTESTINAL STROMAL TUMORS | 2022-05-12 |
20220143009 | COMBINATION OF ANTIBODY-DRUG CONJUGATE AND IMMUNE CHECKPOINT INHIBITOR | 2022-05-12 |
20220143010 | CANCER TREATMENT COMPRISING NALTREXONE AND A CANNABINOID | 2022-05-12 |
20220143011 | METHODS OF TREATMENT WITH CYP3A4 SUBSTRATE DRUGS | 2022-05-12 |
20220143012 | Macromolecule-Supported TLR Agonists | 2022-05-12 |
20220143013 | COMPOSITION AND METHOD FOR REDUCING NEUTROPENIA | 2022-05-12 |
20220143014 | Selective Agonist Of Alpha6 Containing nAChRs | 2022-05-12 |
20220143015 | DIAMINOPYRIMIDINE P2X3 AND P2X2/3 RECEPTOR MODULATORS FOR USE IN THE TREATMENT OF COUGH | 2022-05-12 |
20220143016 | METHOD FOR TREATING A MULTIPLE MYELOMA | 2022-05-12 |
20220143017 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING DIABETIC NEPHROPAPHY INCLUDING ADENOSINE DERIVATIVE | 2022-05-12 |
20220143018 | METHODS OF TREATING DISORDERS USING CSF1R INHIBITORS | 2022-05-12 |
20220143019 | EUTECTIC FORM A OF ELAGOLIX AND PYRIMETHAMINE, PREPARATION METHOD THEREFOR AND USE THEREOF | 2022-05-12 |
20220143020 | 2-AMINOQUINAZOLINONE DERIVATIVE | 2022-05-12 |
20220143021 | ONVANSERTIB FOR INHIBITING NON-ADRENERGIC CONTRACTION OF SMOOTH MUSCLE AND PROSTATE CELL PROLIFERATION | 2022-05-12 |
20220143022 | REPLICATION STRESS PATHWAY AGENT COMPOSITIONS AND METHODS FOR TREATING CANCER | 2022-05-12 |
20220143023 | COMPOUNDS WITH ANTI-TUMOR ACTIVITY AGAINST CANCER CELLS BEARING EGFR OR HER2 EXON 20 INSERTIONS | 2022-05-12 |
20220143024 | METHODS OF USING IMIPRIDONES | 2022-05-12 |
20220143025 | TREATMENT OF AUTOIMMUNE DISEASE | 2022-05-12 |
20220143026 | TRIPLE COMBINATION TO TREAT B-CELL MALIGNANCIES | 2022-05-12 |
20220143027 | Stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid | 2022-05-12 |
20220143028 | INHIBITORS OF ATYPICAL PROTEIN KINASE C AND THEIR USE IN TREATING HEDGEHOG PATHWAY-DEPENDENT CANCERS | 2022-05-12 |
20220143029 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING NONALCOHOLIC STEATOHEPATITIS, HEPATIC FIBROSIS, AND LIVER CIRRHOSIS, COMPRISING ADENOSINE DERIVATIVES | 2022-05-12 |
20220143030 | COMPOUNDS AND METHODS FOR THE TREATMENT OF PKR-ASSOCIATED DISEASES | 2022-05-12 |
20220143031 | OXINDOLES AND METHODS OF USE THEREOF | 2022-05-12 |
20220143032 | 2-PYRIDONES AND METHODS OF USE THEREOF | 2022-05-12 |